"Is RSO good for rheumatoid arthritis?" People living with RA ask this for understandable reasons. Even when the disease itself is well controlled, pain, stiffness, and poor sleep can linger, and many patients are looking for something to add to their routine. This is what the research says, and where it runs out.
There's limited but real evidence that cannabinoids may ease rheumatoid arthritis pain and improve sleep for some people. One small controlled trial of a THC:CBD spray found modest improvements, and surveys of rheumatology patients report frequent use and perceived benefit. There are no clinical trials of RSO specifically, and cannabis has not been shown to slow joint damage, so it isn't a substitute for disease-modifying treatment. If you're considering it, talk with your rheumatologist first, especially if you take methotrexate or other medications processed by the liver.
Rheumatoid arthritis affects roughly 1.3 million adults in the United States, according to a large analysis of healthcare claims. For many of them, modern treatments have changed the course of the disease. But a 2026 scoping review in Rheumatology International notes that persistent pain remains a major unmet need in RA, even when inflammation is well controlled. That gap is where interest in cannabinoids comes from.

What RSO is, and what rheumatoid arthritis does
RSO (Rick Simpson Oil) is a concentrated, whole-plant cannabis extract. It keeps THC or CBD along with minor cannabinoids and terpenes, and it's taken by mouth, either from a syringe or in a pre-measured tablet. Because it's swallowed rather than smoked, its effects begin slowly (often 30 minutes to 2 hours) and last many hours.
Rheumatoid arthritis is an autoimmune disease. The immune system attacks the synovium, the lining of the joints, causing inflammation, swelling, pain, and, over time, damage to cartilage and bone. It's different from osteoarthritis, which is driven mainly by wear and mechanical stress. We cover arthritis more broadly in cannabis and arthritis.
RA pain has more than one source. Some of it comes directly from inflamed joints. Some comes from changes in how the nervous system processes pain signals, which is one reason pain can persist even when blood tests show the disease is under control.
Why researchers are interested: the endocannabinoid system in the joints
The body's endocannabinoid system isn't only in the brain. A 2008 study of joint tissue found cannabinoid receptors (CB1 and CB2) in the synovium of people with rheumatoid arthritis and osteoarthritis, along with the body's own endocannabinoids in their joint fluid. Those endocannabinoids weren't detected in the joint fluid of healthy volunteers. That suggests the system is active in arthritic joints.
A 2015 review in Arthritis Research & Therapy describes several ways cannabinoids might influence arthritis, including effects on immune cells, on pain-sensing nerves, and on the sympathetic nervous system. In animals, the results can be striking: in a mouse model of rheumatoid-like arthritis, oral CBD suppressed the progression of joint inflammation and damage.
Those findings are the reason for clinical studies. They're not, on their own, evidence that cannabis helps people with RA.
What human studies show about cannabis and RA pain
The clinical evidence is small, but it does exist.
The one controlled RA trial. In a 2006 randomized, placebo-controlled study, 58 people with RA used either a THC:CBD mouth spray (Sativex) or placebo in the evening for five weeks. The cannabinoid group had statistically significant improvements in pain on movement, pain at rest, sleep quality, and a standard disease-activity score, with mostly mild side effects. The authors described the differences as small but clinically relevant.
Systematic reviews. A Cochrane review of pain treatments in RA considered that trial and rated the evidence low quality, mainly because it rests on a single small study. A 2024 review in Current Rheumatology Reports reached a similar conclusion: controlled studies in rheumatic diseases have been small and varied, observational data suggest improvements in pain and related symptoms, and high-quality clinical evidence is still limited.
What patients report. In an Ontario study of 799 rheumatology patients, about one in five were using medical cannabis, most commonly for pain, sleep, and anxiety, and 78% of users said it was at least somewhat effective. In a 2024 survey of people with rheumatic conditions in the U.S. and Canada, most cannabis users reported substituting it for some medications, often NSAIDs or opioids. Surveys like these show how people use cannabis; they can't prove it works, and substituting for prescribed medication should always be a decision made with your clinician.
CBD or THC for rheumatoid arthritis?
This is one of the most common questions, including about CBD dosage for RA, and the current evidence leans in a direction many people don't expect.
CBD on its own hasn't performed well in controlled arthritis trials. In a 12-week randomized trial of people with hand osteoarthritis or psoriatic arthritis (another inflammatory arthritis), daily CBD did no better than placebo for pain, sleep, or mood. That study didn't include RA, but it's the closest well-controlled data available.
THC, usually combined with CBD, is what the positive RA trial used, and THC-containing products have the strongest evidence for chronic pain in general, as summarized in our article on which cannabinoids help with pain. The trade-off is intoxication, dizziness, and drowsiness, which is why many people with RA reserve THC for the evening.
CBG has anti-inflammatory activity in laboratory research and is non-intoxicating, but it hasn't been studied in arthritis patients.
How people with RA approach RSO, including microdosing
There are no RSO-specific studies in rheumatoid arthritis, so what follows reflects general cannabis dosing guidance and how patients commonly describe their routines. It isn't individual medical advice.
Evening first. Many people start with a low THC dose in the evening, which matches the timing in the RA trial and puts drowsiness to use for sleep.
Microdosing. "Microdosing" usually means taking small amounts of THC, often 1 to 2.5mg, once or a few times a day, with the goal of some relief without feeling high. There's no RA-specific research on it. It does line up with the conservative approach in a 2021 international consensus on cannabis for chronic pain, which suggested starting low and increasing slowly. A scored tablet split into quarters makes small doses more practical than a syringe; see our guide to RSO tablets.
One change at a time. Keep a short log of dose, timing, pain, sleep, and morning stiffness for a couple of weeks. It helps you and your rheumatologist judge whether anything has actually changed.

Risks and considerations specific to RA
Keep your disease-modifying treatment. Medications such as methotrexate and biologics protect joints from long-term damage. Cannabis hasn't been shown to do that. Stopping them in favor of cannabis can lead to irreversible joint damage.
Liver and drug interactions. Cannabinoids, especially CBD, are processed by liver enzymes that also handle many medications, and CBD can alter drug levels and raise liver enzymes. That matters for people taking methotrexate or leflunomide, which already require liver monitoring, and for anyone on blood thinners.
Dizziness and falls. THC can cause lightheadedness and slower reactions. For people with painful or unstable joints, a fall can be serious, so start low and avoid standing up quickly after a dose.
Choose oral over smoked. Smoking any substance irritates the lungs, which matters for a disease that can itself affect the lungs. Oral products avoid that issue.
The bottom line
For rheumatoid arthritis, cannabis is best thought of as a possible addition to good rheumatology care, aimed at the pain and poor sleep that can persist when the disease is otherwise controlled. The evidence is early, and the most honest promise is a modest one: some people may feel somewhat better, and a careful, low-dose trial with your clinician's input is the way to find out. Emerald Bay's scored RSO tablets come in 10mg to 100mg strengths, which can make low starting doses easier to measure.
Frequently asked questions
Is RSO good for rheumatoid arthritis?
There are no studies of RSO specifically. A small controlled trial of a THC:CBD spray found modest improvements in RA pain and sleep, and many rheumatology patients report benefit, but high-quality evidence is limited and cannabis doesn't replace disease-modifying treatment.
What is microdosing for rheumatoid arthritis?
Microdosing usually means taking very small amounts of THC, often 1 to 2.5mg, to aim for some relief without intoxication. It hasn't been studied in RA, but it reflects the "start low, go slow" approach recommended in clinical dosing guidance.
Can you take RSO with methotrexate?
Ask your rheumatologist or pharmacist first. No well-known direct interaction has been established, but both methotrexate and cannabinoids involve the liver, and CBD can raise liver enzymes, so your care team may want to monitor you more closely.
Is CBD or THC better for rheumatoid arthritis?
The only positive controlled RA trial used THC combined with CBD. CBD alone did not outperform placebo in a recent trial in other inflammatory and degenerative arthritis. THC brings more side effects, so the right balance depends on the person.
This article is educational and doesn't provide medical or dosing advice. Cannabinoid research in rheumatoid arthritis is still emerging; findings vary and individual responses differ. Cannabis is for adults 21+, laws differ by location, and cannabinoids can interact with other medications. Please don't stop or change prescribed RA treatment without your rheumatologist, and discuss cannabis with a healthcare provider who knows your full history, particularly if you're pregnant, nursing, or taking other medications.